Results 71 to 80 of about 16,753 (223)
Journal of Sleep Research, Volume 34, Issue 2, April 2025.Summary Parasomnias and sleep‐related movement disorders (SRMD) are major causes of sleep disorders and may be drug induced. The objective of this study was to conduct a systematic review of the literature to examine the association between drug use and the occurrence of parasomnias and SRMD.
Sylvain Dumont +5 more
wiley +1 more source
Frontiers in Behavioral Neuroscience, 2019 Nicotine is acknowledged as the key addictive compound of tobacco. Varenicline (Champix® or Chantix®), mainly acting as a partial agonist at the α4β2 nicotinic receptor, is an approved smoking cessation pharmacotherapy, although with efficacy limited to ...
Vernon Garcia-Rivas +13 more
doaj +1 more source
Beyond the Ocular Surface: Nasal Sensory Input as a Driver of Reflex Lacrimation in Dogs
Veterinary Ophthalmology, EarlyView.ABSTRACT Objective To evaluate the effect of nasal mucosal anesthesia on aqueous tear secretion in dogs and to compare responses between brachycephalic and non‐brachycephalic breeds. Animal Studied Twenty healthy dogs (10 Australian Shepherds, 10 Boston Terriers). Procedures All dogs received 0.5 mL of 10% lidocaine or saline into one randomly selected
Shelley W. Cochran +2 more
wiley +1 more source
Combining Varenicline (Chantix) with Naltrexone Decreases Alcohol Drinking More Effectively Than Does Either Drug Alone in a Rodent Model of Alcoholism [PDF]
, 2016 Background This study examined whether varenicline (VAR), or naltrexone (NTX), alone or in combination, reduces alcohol drinking in alcohol-preferring (P) rats with a genetic predisposition toward high voluntary alcohol intake.
Dilley, Julian E. +6 more
core +4 more sources
Laryngoscope Investigative Otolaryngology, Volume 11, Issue 1, February 2026.ABSTRACT Objective New head and neck cancer (HNC) patients may prioritize “competing” supportive care needs (SCNs) over smoking cessation, yet the burden of these SCNs according to smoking status is poorly characterized. We aimed to address this gap in knowledge.
Dalia N. Mitchell +9 more
wiley +1 more source
Nicotine dependence and neuropsychotic effects of varenicline
Безопасность и риск фармакотерапии, 2018 Varenicline is a partial agonist of nicotinic acetylcholine receptors for the therapy of nicotine addiction. The efficacy and safety of the use of varenicline in the treatment of nicotine dependence have been demonstrated in clinical trial EAGLES.
T. M. Bukatina +4 more
doaj +1 more source
Comparative Effectiveness of Smoking Cessation Medications: A National Prospective Cohort From Taiwan. [PDF]
PLoS ONE, 2016 Relative effectiveness of smoking cessation medications-varenicline, bupropion and nicotine replacement therapy (NRT)-remains unclear among smokers in real-world settings.
Po-Yin Chang +4 more
doaj +1 more source
Smoking Cessation Agents and Suicide [PDF]
, 2009 The risk is uncertain, so patients should make an informed ...
Lavigne, Jill E
core +2 more sources
Perspectives on addiction‐related problems in Vietnam
Addiction, Volume 121, Issue 2, Page 448-457, February 2026.Abstract The article provides an overview of key substance use and addictive behaviors in Vietnam, alongside the development of addiction science, drawing from a synthesis of literature and the authors' perspectives. Over the last two decades, the primary illicit drug of concern has shifted from heroin to methamphetamine and other psychoactive ...
Nguyen Thu Trang +4 more
wiley +1 more source
Molecular Oncology, Volume 20, Issue 1, Page 6-27, January 2026.The 5th edition of the European Code Against Cancer (ECAC5) contains 14 recommendations on cancer prevention. Here, we update the cancer prevention recommendations on tobacco, second‐hand smoke and alcohol listed as recommendations number 1, 2 and 6. Individuals are advised not to smoke or vape, to quit if they do, keep their home and car smoke‐free ...
Ariadna Feliu +19 more
wiley +1 more source